Reconsidering the Direction of Coronary Revascularization Trials

J Am Coll Cardiol. 2023 May 16;81(19):1974-1978. doi: 10.1016/j.jacc.2023.03.387.

Authors

Gregg W Stone¹, Mario Gaudino²

Affiliations

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: gregg.stone@mountsinai.org.
² Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York, USA.

PMID: 37164530
DOI: 10.1016/j.jacc.2023.03.387

No abstract available

Keywords: clinical trial design; coronary artery disease; endpoints; prognosis; quality of life; randomized trials; revascularization.

MeSH terms

Coronary Artery Bypass
Coronary Artery Disease* / surgery
Humans
Percutaneous Coronary Intervention*
Treatment Outcome